M. Ozawa

发表

Epitopes of the HLA-A, B, C, DR, DQ and MICA antigens.

Junchao Cai, P. Terasaki, N. El-Awar, 2007, Clinical transplants.

Predicting Kidney Graft Failure by HLA Antibodies: a Prospective Trial

P. Terasaki, M. Ozawa, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The effect of pravastatin on acute rejection after kidney transplantation--a pilot study.

S. Katznelson, G. Danovitch, J. Kobashigawa, 1996, Transplantation.

De Novo Donor HLA‐Specific Antibodies after Heart Transplantation Are an Independent Predictor of Poor Patient Survival

N. Banner, P. Terasaki, I. Hamour, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Four‐year Follow‐up of a Prospective Trial of HLA and MICA Antibodies on Kidney Graft Survival

P. Terasaki, R. Castro, M. Ozawa, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

HLA matching.

S. Takemoto, J. Cecka, M. Ozawa, 2020, Clinical transplants.

Predicting Operational Tolerance in Pediatric Living-Donor Liver Transplantation by Absence of HLA Antibodies

K. Waki, T. Kadowaki, P. Terasaki, 2013, Transplantation.

Predictive Value of HLA Antibodies and Serum Creatinine in Chronic Rejection: Results of a 2-year Prospective Trial

P. Terasaki, M. Ozawa, 2005, Transplantation.

Association of kidney transplant failure and antibodies against MICA.

P. Terasaki, A. Cesbron-Gautier, M. Hourmant, 2006, Human immunology.

Serial Ten‐Year Follow‐Up of HLA and MICA Antibody Production Prior to Kidney Graft Failure

P. Terasaki, A. Rosen, Joshua Miller, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Antibodies to HLA-E may account for the non-donor-specific anti-HLA class-Ia antibodies in renal and liver transplant recipients.

P. Terasaki, T. Pham, M. Ravindranath, 2012, International immunology.

The Role of Immunoglobulin-G Subclasses and C1q in De Novo HLA-DQ Donor-Specific Antibody Kidney Transplantation Outcomes

C. Haisch, P. Terasaki, P. Bolin, 2013, Transplantation.

Lung transplantation in the United States: 1990-2005.

Junchao Cai, P. Terasaki, M. Ozawa, 2005, Clinical transplants.

HLA-E monoclonal antibodies recognize shared peptide sequences on classical HLA class Ia: relevance to human natural HLA antibodies.

Junchao Cai, P. Terasaki, M. Ravindranath, 2010, Molecular immunology.

Human Leukocyte Antigen Class II DQ Alpha and Beta Epitopes Identified From Sera of Kidney Allograft Recipients

Junchao Cai, N. Lachmann, P. Terasaki, 2008, Transplantation.

The Importance of Anti‐HLA‐Specific Antibody Strength in Monitoring Kidney Transplant Patients

P. Terasaki, A. Rosen, Joshua Miller, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Liver transplantation in the United States.

P. Terasaki, M. Ozawa, J. Qiu, 2005, Clinical transplants.

14th International HLA and Immunogenetics Workshop Prospective Chronic Rejection Project: a three-year follow-up analysis.

F. Christiansen, N. Lachmann, F. Heinemann, 2007, Clinical transplants.

Incidence and Impact of De Novo Donor-Specific Alloantibody in Primary Renal Allografts

C. Haisch, P. Terasaki, P. Bolin, 2013, Transplantation.

The role of tumor necrosis factor in allograft rejection. I. Evidence that elevated levels of tumor necrosis factor-alpha predict rejection following orthotopic liver transplantation.

D. Chia, K. Olthoff, R. Busuttil, 1990, Transplantation.

Effects of changes in the criteria for nationally shared kidney transplants for HLA-matched patients.

S. Takemoto, P. Terasaki, J. Cecka, 1998, Transplantation.

Frequency of MIC antibody in rejected renal transplant patients without HLA antibody.

P. Terasaki, M. Ozawa, K. Mizutani, 2006, Human immunology.

14th International HLA and Immunogenetics Workshop: report on the Prospective Chronic Rejection Project.

F. Christiansen, F. Heinemann, N. Mehra, 2007, Tissue antigens.

HLA class II DP epitopes.

Junchao Cai, N. El-Awar, C. Deng, 2007, Clinical transplants.

Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.

K. Verbanac, C. Haisch, P. Terasaki, 2006, Clinical transplants.

THE ROLE OF IgA ANTI‐HLA CLASS I ANTIBODIES IN KIDNEY TRANSPLANT SURVIVAL

P. Terasaki, P. Koka, M. Ozawa, 1993, Transplantation.

Longitudinal testing of 266 renal allograft patients for HLA and MICA antibodies: Greenville experience.

C. Haisch, P. Terasaki, P. Catrou, 2006, Clinical transplants.

Binding of IgG to B cell via HLA molecules.

P. Terasaki, M. Ozawa, D. Chia, 1991, Tissue antigens.

No Occurrence of De Novo HLA Antibodies in Patients With Early Corticosteroid Withdrawal in a 5-year Prospective Randomized Study

P. Terasaki, J. Delgado, D. Eckels, 2009, Transplantation.

Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.

M. Ozawa, P. Lee, 2008, Clinical transplants.

LONG TERM EFFECT OF INCREASED MYCOPHENOLIC ACID (MPA) ON DONOR SPECIFIC HLA ANTIBODY (DSA) STRENGTH AND IGG LEVELS IN KIDNEY TRANSPLANT RECIPIENTS: 1873

C. Haisch, P. Terasaki, P. Bolin, 2010 .

Retrospective antibody analysis of thirty patients with kidney graft failure.

P. Terasaki, Masashi Kato, M. Ozawa, 2006, Clinical transplants.

Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.

C. Hung, P.-C. Lee, M. Ozawa, 2009, Transplantation proceedings.

The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.

S. Katznelson, J. Kobashigawa, P. Terasaki, 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

A report of the epidemiology of de novo donor-specific anti-HLA antibodies (DSA) in "low-risk" renal transplant recipients.

C. Haisch, P. Bolin, P. Catrou, 2011, Clinical transplants.

The Role of Immunoglobulin-G Subclasses and C1q in De Novo HLA-DQ Donor-Specific Antibody Kidney Transplantation Outcomes

C. Haisch, P. Terasaki, P. Bolin, 2013, Transplantation.

Factors affecting outcomes of liver transplantation: an analysis of OPTN/UNOS database.

J. Hoshino, M. Ozawa, H. Ohe, 2011, Clinical transplants.

The clinical impact of humoral immunity in pediatric renal transplantation.

M. Sarwal, E. Kamil, T. Sigdel, 2013, Journal of the American Society of Nephrology : JASN.